EcoDrugPlus

P2y Purinoceptor 12-Like

Ensembl ID : ENSPKIG00000010302
Gene Symbol: LOC111849405
3 Cross references
180 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPKIG00000014884
Gene Symbol: PIM3
3 Cross references
128 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPKIG00000015106
Gene Symbol: PIM3
3 Cross references
136 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPKIG00000024636
Gene Symbol: RAF1
3 Cross references
152 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase A

Ensembl ID : ENSPKIG00000017461
Gene Symbol: RAF1A
1 Cross references
207 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSPKIG00000006028
Gene Symbol: ROCK1
3 Cross references
215 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 2

Ensembl ID : ENSPKIG00000012291
Gene Symbol: ROCK2
3 Cross references
225 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 2

Ensembl ID : ENSPKIG00000000147
Gene Symbol: ROCK2
4 Cross references
227 Possible Orthologues:

Sem1 26s Proteasome Subunit

Ensembl ID : ENSPKIG00000001755
Gene Symbol: SEM1
1 Cross references
155 Possible Orthologues:

Tgf-Beta Receptor Type-1

Ensembl ID : ENSPKIG00000006898
Gene Symbol: LOC111838972
3 Cross references
206 Possible Orthologues:

Tgf-Beta Receptor Type-1-Like

Ensembl ID : ENSPKIG00000007392
Gene Symbol: LOC111851387
3 Cross references
156 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSPKIG00000022506
Gene Symbol: TTK
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).